öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º³ÂÐÂÁÖ
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º611

ËùÊôԺУ£º¹ãÖÝÖÐÒ½Ò©´óѧ
ËùÊôԺϵ£º201»ù´¡Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ÉúÎïÐÅϢѧºÍÖÐÒ½Ò©´óÊý¾Ý·ÖÎö
Ñо¿ÁìÓò£º ÉúÎïÐÅϢѧºÍÖÐÒ½Ò©´óÊý¾Ý·ÖÎö [ÊÕÆð]




¸öÈ˼òÊö :
¸öÈ˼òÊö
¹ã¶«ÈË£¬ºº×壬¸±½ÌÊÚ£¬²©Ê¿£¬²©Ê¿Ñо¿Éúµ¼Ê¦
Ö÷ÒªÈÙÓþ
¡¶±ÇÑÊ°©»¼ÕßÉú´æÖÊÁ¿Á¿±íµÄÑз¢ÓëÓ¦Óá·£¬2013Äê¹ã¶«Ê¡¿Æ¼¼½ø²½½±£¬ÈýµÈ½±¡£
¡¶ÖØÖ¢¼¡ÎÞÁ¦PROÁ¿±íµÄÑÐÖƼ°ÆäÓ¦Óá·£¬2013Äê¶ÈÖлªÖÐҽҩѧ»á¿Æѧ¼¼Êõ½±£¬ÈýµÈ½±£»¹ãÖÝÖÐÒ½Ò©´óѧ¿Æ¼¼½ø²½½±£¬Ò»µÈ½±¡£
¡¶Ó뽡¿µÓйØÉú´æÖÊÁ¿²â¶¨ÏµÁÐÁ¿±íµÄÑÐÖÆÓëÓ¦Óá·£¬2010Äê¹ã¶«Ê¡¿Æ¼¼½ø²½½±£¬¶þµÈ½±¡£
¹ã¶«Ê¡¸ßµÈѧУÓÅÐãÇàÄê½Ìʦ
¹ã¶«Ê¡¸ßµÈѧУ¡°Ç§°ÙÊ®È˲ÅÅàÑø¹¤³Ì¡±Ð£¼¶ÅàÑø¶ÔÏó
¹ãÖÝÖÐÒ½Ò©´óѧ¡°ÇàÄêÓ¢²Å¡±ÅàÑø¶ÔÏó

¿ÆÑй¤×÷ :
¹¤×÷¾­Àú
2008Äê7ÔÂÖÁ½ñÔÚ¹ãÖÝÖÐÒ½Ò©´óѧԤ·ÀҽѧºÍÎÀÉúͳ¼Æѧ½ÌÑÐÊÒ¹¤×÷¡£Æä¼ä£¬2014Äê12Ô½úÉýΪ¸±½ÌÊÚ
2013Äê10ÔÂÖÁ2014Äê3Ôµ£ÈÎÏã¸Û½þ»á´óѧ·ÃÎÊѧÕß
ѧÊõ¼æÖ°
ÖлªÒ½Ñ§»á¼±Õïҽѧ·Ö»áÁÙ´²Ñо¿×鸱×鳤
ÊÀ½ç·º»ªÍ³¼Æѧ»á»áÔ±
¹ú¼ÊÉúÎïͳ¼Æѧ»áÖйú·Ö»á»áÔ±
ÊÀ½ç»ªÈËÉú´æÖÊÁ¿Ñ§»á»áÔ±
ÖйúÖÐÎ÷Ò½½áºÏѧ»á»áÔ±
ÖйúÎÀÉúÐÅϢѧ»áҽѧͳ¼Æ½ÌÓýöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á»áÔ±
ÖлªÔ¤·Àҽѧ»áÑ­Ö¤Ô¤·ÀҽѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áѭ֤ҽѧ·½·¨Ñ§×é»áÔ±
¹ã¶«Ê¡ÖÐÎ÷Ò½½áºÏѧ»á°©Ö¢Ñ§»á»áÔ±
¹ã¶«ÉúÎïÐÅϢѧѧ»á»áÔ±
¹ã¶«Ê¡ÇàÄê¿Æѧ¼ÒЭ»áµÚËĽì»áÔ±
¡°Oncotarget¡±£¬¡°valueinhealth¡±£¬¡°ChineseJournalofIntegrativeMedicine¡±£¬¡°healthandqualityofliferesearch¡±£¬¡°Biomedicine&Pharmacotherapy¡±£¬¡°INQUIRY¡±£¬¡°DisabilityandRehabilitation¡±Éó¸åÈË
¿ÆÑÐÏîÄ¿
¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£º»ùÓÚ±´Ò¶Ë¹ÀíÂÛ¹¹½¨ÖÐÒ½Ò©µ¥²¡ÀýËæ»ú¶ÔÕÕÊÔÑéÄ£Ðͼ°ÆäÁÙ´²ÑéÖ¤Ñо¿£¬2018-2021Ä꣬55Íò£¬Ö÷³Ö
¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£ºÌ½Ë÷ÊʺÏÖÐÒ½Ò©µ¥²¡ÀýËæ»ú¶ÔÕÕÊÔÑéµÄÊýѧģÐͼ°ÆäÁÙ´²ÑéÖ¤£¬2017-2019Ä꣬10Íò£¬Ö÷³Ö
¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄê»ù½ð£º¡°»ùÓÚ¶àάDZ±äÁ¿Ä£ÐͺÍÊý¾ÝÍÚ¾òµÄÀ£ÑñÐԽ᳦Ñ×ÖÐÒ½Ö¤ºòÁ¿»¯·½·¨Ñ§Ñо¿¡±£¬2015-2017Ä꣬23Íò£¬Ö÷³Ö
¹ãÖÝÖÐÒ½Ò©´óѧ¸ßˮƽ´óѧ½¨ÉèÏîÄ¿£ºÁëÄÏÖÐÒ©ÀíÆø»¯Ìµ½µ×Ç·ÀÖιÚÐIJ¡Ìµ×Ç֤̦Äå΢Éú̬¼°ÉúÎïÐÅϢѧ»úÖÆÑо¿£¬20Íò£¬Ö÷³Ö
¹ú¼ÒÖصã»ù´¡Ñо¿·¢Õ¹¼Æ»®£¨973¼Æ»®£©£º¡°¹ÚÐIJ¡Ìµðö»¥½áÖ¤ÁÙ´²±íÕ÷¼°ÆäÑݱä¹æÂÉÑо¿¡±£¬2014-2019Ä꣨²Î¼Ó£©
Ö÷ÒªÂÛÎÄ
ChenXL(#*),ZhongLH(#),WenY,LiuTW,LiXy,HouZk,HuY,MoCW,LiuFB(*).Inflammatoryboweldisease-specifichealth-relatedqualityoflifeinstruments:asystematicreviewofmeasurementproperties.HealthandQualityofLifeOutcomes,2017,15:177.DOI10.1186/s12955-017-0753-2
ChenXL,MoCW,LuLY,GaoRY,XuQ,WuMF,ZhouQY,HuY,ZhouX,LiXT.MethologicalQualityofSystematicReviewsandMeta-AnalysesonAcupunctureforStroke:AReviewofReview.ChinJIntegrMed.2017Sep13.doi:10.1007/s11655-017-2764-6.
ChenXL(#),ChenZQ(#),ZhuSL,LiuTW,WenY,SuYS,XiXJ,HuY,LianL(*),LiuFB(*).Prognosticvalueoftransforminggrowthfactor-betainpatientswithcolorectalcancerwhoundergosurgery:ameta-analysis.BMCCancer,2017,17(1):240.doi:10.1186/s12885-017-3215-7
HuangCY(#),ZhouQY(#),HuY,WenY,QiuZW,LiangMG,MoJL,XuJH,SunC,LiuFB(*),ChenXL(*).Hepatocytegrowthfactorisaprognosticmarkerinpatientswithcolorectalcancer:ameta-analysis.Oncotarget,2017,8(14):23459-23469
ChenXL(#),SheSF(#),LiYH,ZhangWJ,TangYT,ZhuangKH,PanYB(*),LiuFB(*),HeWL(*).Azathioprine/6-mercaptopurineversus5-aminosalicylicfortreatmentofinflammatoryboweldisease.IntJClinExpMed2017,10(2):1927-1936
HeWL,ZhangH,HanF,ChenXL,LinR,WangW,QiuHB,ZhuangZ,LiaoQ,ZhangW,CaiQ,CuiY,JiangW,WangH,KeZ.CD155T/TIGITSignalingRegulatesCD8+TCellMetabolismandPromotesTumorProgressioninHumanGastricCancer.CancerRes.2017Sep7.pii:canres.0381.2017.doi:10.1158/0008-5472.CAN-17-0381.[Epubaheadofprint]
HouZK,ChangX,LiuFB,XieN,GuoN,ChenXL.ControversiesonthevaluesforhealthinstrumentsofChinesemedicine.ChinJIntegrMed.2017,23(2):146-152.
ChenX(#),HouJ(#),YuanY,HuangC,LiuT,MoC,LiH,ChenB,XuQ,HouZ,HeW(*),LiuF(*).Adalimumabformoderatelytoseverelyactiveulcerativecolitis:Asystematicreviewandmeta-analysis.Biodrugs,2016,30(3):207-217
SuY(#),MoCW(#),ChengWQ,WangL,XuQ,WuZC,WuZL,LiuLZ,ChenXL(*).Developmentandvalidationofqualityoflifescaleofnasopharyngealcarcinomapatients:TheQOL-NPC(version2).HealthQualLifeOut,2016,14:76DOI10.1186/s12955-016-0480-0
ZhangJ(#),GaoF(#),YangA,ChenW,ChenS,LiH,ZhangX,YangZ,ChenX(*),SongM(*).Epidemiologiccharacteristicsoforalcancer:single-centeranalysisof4097patientsfromtheSunYat-senUniversityCancerCenter.ChineseJournalofCancer,2016,35(1):24.doi:10.1186/s40880-016-0078-2
ZhengQ,TianQ,HaoC,GuJ,TaoJ,LiangZ,ChenX,FangJ,RuanJ,AiQ,HaoY.Comparisonofattitudestowarddisabilityandpeoplewithdisabilityamongcaregivers,thepublic,andpeoplewithdisability:findingsfromacross-sectionalsurvey.BMCPublicHealth.2016,16(1):1024.
YeX,LuD,ChenX,LiS,ChenY,DengL.AMulticenter,Randomized,Double-Blind,Placebo-ControlledTrialofShuangbaiSanforTreatingPrimaryLiverCancerPatientsWithCancerPain.JournalofPainandSymptomManagement,2016,51(6):979¨C986
DiaoD,WangL,WanJ,ChenZ,PengJ,LiuH,ChenX,WangW,ZouL.MEK5overexpressionisassociatedwiththeoccurrenceanddevelopmentofcolorectalcancer.BMCCancer.2016,16:302.doi:10.1186/s12885-016-2327
HeW(#),TuJ(#),HuoZ,LiY,PengJ,QiuZ,LuoD,KeZ(*),ChenX(*).Surgicalinterventionsforgastriccancer:areviewofsystematicreviews.IntJClinExpMed,2015,8(8):13657-13669
HouM,ChengZ,ShenH,HeS,LiY,PanY,FengC,ChenX,ZhangY,LinM,WangL,KeZ.HighexpressionofCTHRC1promotesEMTofepithelialovariancancer(EOC)andisassociatedwithpoorprognosis.Oncotarget.2015,6(34):35813-29.doi:10.18632/oncotarget.5358
XieM,ZhuJ,HeX,YangZ,ChenX,LanP,LianL.LiverMetastasisfromColorectalCancerintheElderly:IsSurgeryJustifiedDigDisSci,2015,60(12):3525-35.DOI10.1007/s10620-015-3789-3
ChenXL(#),QiuZW(#),GuMF(*),SuY,LiuLZ(*),LiuY,MoCW,XuQ,SunJ,LiDH.TranslationandvalidationoftheChineseversionofthequalityofliferadiationtherapyinstrumentandthehead&neckmodule(QOL-RTI/H&N).HealthQualLifeOut,2014,12:51.doi:10.1186/1477-7525-12-51
ChenX,ChenP(*).AComparisonofFourMethodsfortheAnalysisofN-of-1Trials.PLOSONE,2014,9(2):e87752.doi:10.1371/journal.pone.**
HeW(#),LiY(#),ChenX(#),LuL,TangB,WangZ,PanY,CaiS,HeY(*),KeZ(*).miR-494actsasananti-oncogeneingastriccarcinomabytargetingc-myc.JGASTROENHEPATOL.2014,29(7):1427-34.doi:10.1111/jgh.12558
HeWL,LiYH,HouWJ,KeZF,ChenXL,LuLY,CaiSR,SongW,ZhangCH,HeYL.RAD51potentiatessynergisticeffectsofchemotherapywithPCI-24781andcis-diamminedichloroplatinumongastriccancer.WorldJGastroenterol,2014,20(29):10094-107.doi:10.3748/wjg.v20.i29.10094
SunP,ChenC,ChenXL,ChengYK,ZengL,ZengZJ,LiuLZ,SuY,GuMF.ProposalofaclinicaltypingsystemandgenerationofaprognosticmodelinpatientswithnasopharyngealcarcinomafromSouthernChina.JournalofBUON,2014,19(2):474-483
SunP,ChenC,ChengYK,ZengZJ,ChenXL,LiuLZ,GuMF.SerologicbiomarkersofEpstein-BarrviruscorrelatewithTNMclassificationaccordingtotheseventheditionoftheUICC/AJCCstagingsystemfornasopharyngealcarcinoma.EuropeanArchivesofOto-Rhino-Laryngology,2014,271(9):2545-54.doi:10.1007/s00405-013-2805-5
LiuFeng-bin,JinYong-xing,WuYu-hang,HouZheng-kun,ChenXin-lin.TranslationandPsychometricEvaluationoftheChineseVersionofFunctionalDigestiveDisordersQualityofLifeQuestionnaire.DigestiveDiseasesandSciences.2014,59:390-420.doi:10.1007/s10620-013-2897-1
ZhengQL,TianQ,HaoC,GuJ,Lucas-CarrascoR,TaoJT,LiangZY,ChenXL,FangJQ,RuanJH,AiQX,HaoYT.Theroleofqualityofcareandattitudetowardsdisabilityintherelationshipbetweenseverityofdisabilityandqualityoflife:findingsfromacross-sectionalsurveyamongpeoplewithphysicaldisabilityinChina.HealthandQualityofLifeOutcomes,2014,12:25doi:10.1186/1477-7525-12-25
HeW,TangB,YangD,LiY,SongW,CheangT,ChenX,LiY,ChenL,ZhanW,LiW,HeY.Double-positiveexpressionofhigh-mobilitygroupbox1andvascularendothelialgrowthfactorCindicatesapoorerprognosisingastriccancerpatients.WorldJournalofSurgicalOncology.2013,11:161.doi:10.1186/1477-7819-11-161.
HeWL,LiYH,YangDJ,SongW,ChenXL,LiuFK,WangZ,LiW,ChenW,ChenCY,HeYL,ZhanWH.CombinedevaluationofcentromereproteinHandKi-67asprognosticbiomarkerforpatientswithgastriccarcinoma.Europeanjournalofsurgicaloncology,2013,39(2):141-149.doi:10.1016/j.ejso.2012.08.023
GuMF(#),SuY(#),ChenXL(*),HeWL,HeZY,LiJJ,ChenMQ,MoCW,XuQ,DiaoYM.QualityoflifeandradiotherapycomplicationsofChinesenasopharyngealcarcinomapatientsatdifferent3DCRTstage,AsianPacificJournalofcancerprevention,2012,13(1):75-79
LiuFB,ChenXL,GuoL,LiuXB.Evaluationofapatient-reportedoutcomescaleformyastheniagravispatientsinChina.ChineseJournalofIntegrativeMedicine,2012,18(10):737-745
ÖÐÎÄÆÚ¿¯85ƪ¡£

½ÌÓý±³¾° :
ÖÐÎ÷Ò½½áºÏ»ù´¡£¬ÖÐÒ½´óÊý¾Ýͳ¼Æ·ÖÎö£¬ÉúÎïÐÅϢѧµÄÓ¦ÓÃÑо¿2008Äê±ÏÒµÓÚÖÐɽ´óѧÁ÷Ðв¡ÓëÎÀÉúͳ¼ÆѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñ˶ʿѧλ
2014Äê±ÏÒµÓÚÄÏ·½Ò½¿Æ´óѧÁ÷Ðв¡ÓëÎÀÉúͳ¼ÆѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñ²©Ê¿Ñ§Î»